Bayer AG has said that it has paid $402.6 million in one category of Yaz and Yasmin blood clot lawsuits (vein clots), resolving 1,877 cases. The average settlement is approximately $212,000 a case, Bloomberg reports. Bayer said the clot injury claims were “alleged in about 6,000 claims.”
The company also said that it increased the amount it has set in reserve for Yaz lawsuits to approximately $610.5 million. In a statement emailed to Bloomberg, the company said, “We believe we have made appropriate provisions for most of the cases we consider to be worthy of settlement with these accounting measures.”
Bayer executives reported in a stockholder’s newsletter that more than 12,000 lawsuits were filed over Yasmin alleging the oral birth control pill caused blood clots and gallbladder injury. An attorney involved in the cases says the company is rejecting gallbladder injury and gallstone claims, as well as claims that the oral contraceptives cause arterial clots.
All federally filed Yaz and Yasmin lawsuits are consolidated in U.S. District Court in East St. Louis, Illinois under Judge David Herndon. Judge Herndon appointed Stephen Saltzburg as special mediator to help both sides achieve litigation settlements. Earlier this month, Saltzburg said that “There are always some holdouts, but I think we will settle the bulk of these cases next year.”